Literature DB >> 22212966

Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.

Steven J Jacobsen1, Debra J Jacobson, Michaela E McGree, Jennifer L St Sauver, George G Klee, Cynthia J Girman, Michael M Lieber.   

Abstract

OBJECTIVE: To determine the distribution of longitudinal changes in serum prostate-specific antigen (PSA) levels from a population-based sample of men. PATIENTS AND METHODS: In this prospective cohort study, a random sample of Olmsted County, Minnesota, men aged 40 to 79 years in 1990 were followed up biennially from January 1, 1990, through August 29, 2007. Serum PSA levels were determined at each examination, and men were censored for follow-up with a diagnosis of prostate cancer or treatment for benign prostatic hyperplasia. The empirical distributions of annual percent change and annual absolute change in serum PSA level were calculated and tabulated, including the median and 75th and 95th percentiles.
RESULTS: For men with PSA measurements 2 years apart, the median annual percent change in serum PSA level was 4.83% and the 95th percentile was about 49.76%. The variability in estimated annual change decreased with increasing time between assessments, with a 95th percentile of 21.82% after 8 or more years between assessments. Although the median absolute change per year increased with increasing age, the median percent change per year was fairly consistent across age groups.
CONCLUSION: These data demonstrate that, with shorter intervals between assessments, greater variability should be expected. These distributions should prove helpful to patients and clinicians in interpreting changes in serum PSA levels observed in typical clinical practices.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212966      PMCID: PMC3538390          DOI: 10.1016/j.mayocp.2011.09.002

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  36 in total

1.  Natural history of prostatism: risk factors for acute urinary retention.

Authors:  S J Jacobsen; D J Jacobson; C J Girman; R O Roberts; T Rhodes; H A Guess; M M Lieber
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

2.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

3.  Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.

Authors:  R B Nadler; P A Humphrey; D S Smith; W J Catalona; T L Ratliff
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

4.  Longitudinal evaluation of prostate-specific antigen levels in a case-control study.

Authors:  F De Biasi; D Londero; S Praturlon; A Di Donna; G A Feruglio; U P Guerra
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

5.  Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial.

Authors:  H A Guess; J F Heyse; G J Gormley; E Stoner; J E Oesterling
Journal:  Urol Clin North Am       Date:  1993-11       Impact factor: 2.241

6.  Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.

Authors:  S J Jacobsen; G G Klee; H Lilja; G L Wright; J E Oesterling
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

7.  The natural history of prostatism: the effects of non-response bias.

Authors:  L A Panser; C G Chute; H A Guess; J J Larsonkeller; C J Girman; J E Oesterling; M M Lieber; S J Jacobsen
Journal:  Int J Epidemiol       Date:  1994-12       Impact factor: 7.196

8.  Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.

Authors:  H B Carter; J D Pearson; Z Waclawiw; E J Metter; D W Chan; H A Guess; P C Walsh
Journal:  Urology       Date:  1995-04       Impact factor: 2.649

9.  Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.

Authors:  S J Jacobsen; H Lilja; G G Klee; G L Wright; K Pettersson; J E Oesterling
Journal:  Urology       Date:  1994-10       Impact factor: 2.649

Review 10.  Natural history of changes in prostate specific antigen in early stage prostate cancer.

Authors:  J D Pearson; H B Carter
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more
  3 in total

1.  Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.

Authors:  Lila J Finney Rutten; Robert M Jacobson; Patrick M Wilson; Debra J Jacobson; Chun Fan; John B Kisiel; Seth Sweetser; Sidna M Tulledge-Scheitel; Jennifer L St Sauver
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

2.  Changes in serum prostate-specific antigen levels.

Authors:  David L Keller
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

3.  Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.

Authors:  Aruna V Sarma; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; George G Klee; Michael M Lieber; Cynthia J Girman; John M Hollingsworth; Steven J Jacobsen
Journal:  Urology       Date:  2013-10-16       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.